| 000 | 01128 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516123921.0 | ||
| 264 | 0 | _c20130509 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1747-4094 | ||
| 024 | 7 |
_a10.1586/ehm.12.55 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTibes, Raoul | |
| 245 | 0 | 0 |
_aJAK inhibition: the key to treating myeloproliferative neoplasm? _h[electronic resource] |
| 260 |
_bExpert review of hematology _cDec 2012 |
||
| 300 |
_a583-5 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aBone Marrow Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xdrug therapy |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrazoles _xtherapeutic use |
| 650 | 0 | 4 | _aPyrimidines |
| 650 | 0 | 4 | _aQuality of Life |
| 700 | 1 | _aBogenberger, James M | |
| 700 | 1 | _aMesa, Ruben A | |
| 773 | 0 |
_tExpert review of hematology _gvol. 5 _gno. 6 _gp. 583-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/ehm.12.55 _zAvailable from publisher's website |
| 999 |
_c22324257 _d22324257 |
||